Gilead Sciences
Biopharma company known for antiviral medicines (HIV) and a growing oncology footprint (including cell therapy).
Therapeutic areas
Selected products and programs
Linked curated drug profiles
Selected active clinical trials
Phase 3 · Recruiting · Triple Negative Breast Cancer
Study of Lenacapavir, Teropavimab, and Zinlirvimab Versus Cabotegravir and Rilpivirine in Virologically Suppressed Adults With HIV-1 on Oral Daily Antiretroviral TherapyPhase 3 · Recruiting · HIV Infections
Study of Lenacapavir, Teropavimab, and Zinlirvimab in Virologically Suppressed Adults With HIV-1 on Stable Oral Treatment RegimensPhase 3 · Recruiting · HIV-1-infection
Study of Sacituzumab Govitecan Versus Standard of Care in Participants With Previously Treated Extensive Stage Small Cell Lung CancerPhase 3 · Recruiting · Extensive Stage Small Cell Lung Cancer (ES-SCLC)
Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated CirrhosisPhase 3 · Recruiting · Primary Biliary Cholangitis
Study of GS-4571 in Healthy Participants, Nondiabetic Obese Participants, and Nonobese Participants With Type 2 Diabetes Mellitus (T2DM)Phase 1 · Recruiting · Weight Management
Selected patent records
tenofovir alafenamide fumarate · Expires 2026-08-27
US 7635704tenofovir alafenamide fumarate · Expires 2026-10-26
US 8981103tenofovir alafenamide fumarate · Expires 2026-10-26
US 7700645tenofovir alafenamide fumarate · Expires 2026-12-26
US 7176220*PEDtenofovir alafenamide fumarate · Expires 2027-02-27
US 7635704*PEDtenofovir alafenamide fumarate · Expires 2027-04-26
Primary and company sources
Company and pipeline information can change. Verify material decisions against the linked primary sources.
Evidence & limits
Source: Open the source record
- Record identifier
- /companies/gilead-sciences/
- Event / action date
- Not separately retained
- Source update date
- Not separately retained
- Platform retrieval / processing date
- Not separately retained
What it supports. Connections found through the catalog, identifiers, or name and alias matching, with source links where retained.
Limits. A company association is not proof of ownership or sponsorship of every linked record. Product, substance, parent-company, and subsidiary relationships may differ.
Connection basis. Catalog, identifier, or normalized name association. Product and company connections are research leads, not ownership determinations.